{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T22:47:51Z","timestamp":1787957271152,"version":"build-2784847793"},"reference-count":26,"publisher":"Informa UK Limited","issue":"2","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Dermatological Treatment"],"published-print":{"date-parts":[[2022,2,17]]},"DOI":"10.1080\/09546634.2020.1774488","type":"journal-article","created":{"date-parts":[[2020,5,23]],"date-time":"2020-05-23T13:55:02Z","timestamp":1590242102000},"page":"769-773","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":14,"title":["The efficacy and safety of oral low dose naltrexone versus placebo in the patients with lichen planopilaris: a randomized controlled clinical trial"],"prefix":"10.1080","volume":"33","author":[{"given":"Vahideh","family":"Lajevardi","sequence":"first","affiliation":[{"name":"Department of Dermatology, Razi Dermatological Hospital, Tehran University of Medical Sciences","place":["Tehran, Iran"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fereshteh","family":"Salarvand","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Razi Dermatological Hospital, Tehran University of Medical Sciences","place":["Tehran, Iran"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Ghiasi","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Razi Dermatological Hospital, Tehran University of Medical Sciences","place":["Tehran, Iran"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Nasimi","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Razi Dermatological Hospital, Tehran University of Medical Sciences","place":["Tehran, Iran"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Taraz","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, School of Pharmacy, Tehran University of Medical Sciences","place":["Tehran, Iran"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2020,6,8]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.sder.2008.12.006"},{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2008.08591.x"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12139"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1001\/archdermatol.2008.590"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2009.10.025"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2007.09.003"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2007.01045.x"},{"key":"e_1_3_3_9_1","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/ana.22006","article-title":"Pilot trial of low-dose naltrexone and quality of life in multiple sclerosis","volume":"68","author":"Cree BAC","year":"2010","unstructured":"Cree BAC, Kornyeyeva E, Goodin DS. Pilot trial of low-dose naltrexone and quality of life in multiple sclerosis. Ann Neurol [Internet]. 2010;68:145\u2013150.","journal-title":"Ann Neurol [Internet]"},{"key":"e_1_3_3_10_1","first-page":"205521731667224","article-title":"Long-term treatment with low dose naltrexone maintains stable health in patients with multiple sclerosis","volume":"2","author":"Ludwig MD","year":"2016","unstructured":"Ludwig MD, Turel AP, Zagon IS, et\u00a0al. Long-term treatment with low dose naltrexone maintains stable health in patients with multiple sclerosis. Mult Scler J Exp Transl Clin. 2016;2:2055217316672242.","journal-title":"Mult Scler J Exp Transl Clin"},{"key":"e_1_3_3_11_1","unstructured":"Ringerike T Pike E Nevjar J et\u00a0al. The use of naltrexone in low doses beyond the approved indication [Internet]. Use naltrexone low doses beyond approv. Indic. Knowledge Centre for the Health Services at The Norwegian Institute of Public Health (NIPH); 2015. [cited 2018 Jan 4]. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28510411."},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2017.2445"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2017.2446"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jisp.2017.10.012"},{"key":"e_1_3_3_15_1","first-page":"1140","article-title":"Novel treatment using low-dose naltrexone for lichen planopilaris","volume":"16","author":"Strazzulla LC","year":"2017","unstructured":"Strazzulla LC, Avila L, Lo KS, et\u00a0al. Novel treatment using low-dose naltrexone for lichen planopilaris. J Drugs Dermatol. 2017;16:1140\u20131142.","journal-title":"J Drugs Dermatol"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1460-9568.2008.06321.x"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-014-2517-2"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2009.08.054"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-015-0122-z"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.12.031"},{"key":"e_1_3_3_21_1","first-page":"739","article-title":"Beta-endorphin prevents collagen induced arthritis by neuroimmuno-regulation pathway","volume":"26","author":"Yin H","year":"2005","unstructured":"Yin H, Yu M, Cheng H, et\u00a0al. Beta-endorphin prevents collagen induced arthritis by neuroimmuno-regulation pathway. Neuroendocr Lett [Internet]. 2005;26:739\u2013744.","journal-title":"Neuroendocr Lett [Internet]"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2007.01045.x"},{"issue":"4","key":"e_1_3_3_23_1","article-title":"Low-dose naltrexone (LDN)\u2014review of therapeutic utilization","volume":"6","author":"Toljan K","year":"2018","unstructured":"Toljan K, Vrooman B. Low-dose naltrexone (LDN)\u2014review of therapeutic utilization. Med Sci. 2018;6(4):82.","journal-title":"Med Sci"},{"key":"e_1_3_3_24_1","unstructured":"Muller G Grieshaber R Talley J et\u00a0al. Compounded low-dose naltrexone for the treatment of guttate psoriasis: a case report. europepmc.org [Internet]. [cited 2020. Feb 6]; Available from: https:\/\/europepmc.org\/abstract\/med\/30021181."},{"key":"e_1_3_3_25_1","article-title":"Low-dose naltrexone for pruritus in systemic sclerosis","author":"Frech T","year":"2020","unstructured":"Frech T, Novak K, Revelo M, et\u00a0al. Low-dose naltrexone for pruritus in systemic sclerosis. Hindawi.com [Internet]. 2020. [cited Feb 6]. Available from: https:\/\/www.hindawi.com\/journals\/ijr\/2011\/804296\/abs\/.","journal-title":"Hindawi.com [Internet]"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2017.5463"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.16045"}],"container-title":["Journal of Dermatological Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/09546634.2020.1774488","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T12:28:35Z","timestamp":1770121715000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/09546634.2020.1774488"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,8]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2,17]]}},"alternative-id":["10.1080\/09546634.2020.1774488"],"URL":"https:\/\/doi.org\/10.1080\/09546634.2020.1774488","relation":{},"ISSN":["0954-6634","1471-1753"],"issn-type":[{"value":"0954-6634","type":"print"},{"value":"1471-1753","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,8]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijdt20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijdt20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-04-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-05-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-06-08","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}